Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Evidence-Grounded Research Assistant for Functional Genomics and Drug Target Assessment. | bioRxiv | 2025 | 41502944 | PubTator, text mining | PubMed |
| ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus). | bioRxiv | 2025 | 41256654 | PubTator, text mining | PubMed |
| The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy. | ERJ Open Res | 2025 | 41220827 | PubTator, text mining | PubMed |
| Research progress on sarcopenia in the musculoskeletal system. | Bone Res | 2025 | 40987776 | PubTator, text mining | PubMed |
| Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions. | Int J Nanomedicine | 2025 | 40933023 | PubTator, text mining | PubMed |
| Activin A/Follistatin Axis in Airway Diseases and its Association With Recurrent Exacerbations. | In Vivo | 2025 | 40877175 | PubTator, text mining | PubMed |
| CryoEM structure of ALK2:BMP6 reveals distinct mechanism that allow ALK2 to interact with both BMP and activin ligands. | Proc Natl Acad Sci U S A | 2025 | 40854140 | PubTator, text mining | PubMed |
| Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies. | Medicines (Basel) | 2025 | 40843857 | PubTator, text mining | PubMed |
| Alpha-Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models. | J Cachexia Sarcopenia Muscle | 2025 | 40810552 | PubTator, text mining | PubMed |
| The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review. | J Diabetes | 2025 | 40739991 | PubTator, text mining | PubMed |
| Paneth cells inhibit intestinal stem cell proliferation through the bone morphogenic protein 7 pathway under rotavirus-mediated intestinal injury. | World J Gastroenterol | 2025 | 40678707 | PubTator, text mining | PubMed |
| Molecular mechanism of Activin receptor inhibition by DLK1. | Nat Commun | 2025 | 40593645 | PubTator, text mining | PubMed |
| Transcriptome-Wide Sequencing Identifies Non-Coding RNAs and Their Competing Endogenous RNA Networks During the Stages of pPGCLCs-Induced Differentiation. | Stem Cell Rev Rep | 2025 | 40439841 | PubTator, text mining | PubMed |
| Circular RNA profiling reveals an abundant circPTK2 that contributes everolimus-induced endothelial cell dysfunction via regulating miR-1-5p/ACVR2B/StarD13 axis. | Acta Cardiol | 2025 | 40435286 | PubTator, text mining | PubMed |
| Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes. | J Clin Invest | 2025 | 40424086 | PubTator, text mining | PubMed |
| Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer. | Ann Med | 2025 | 40372974 | PubTator, text mining | PubMed |
| INHBA+ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma. | BMC Cancer | 2025 | 40355814 | PubTator, text mining | PubMed |
| Gel Electrophoretic Detection of Black Market ACE-031. | Drug Test Anal | 2025 | 40312924 | PubTator, text mining | PubMed |
| Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder. | Front Mol Biosci | 2025 | 40144023 | PubTator, text mining | PubMed |
| N-glycosylation of ACTRIIB enhances protein stability leading to rapid cell proliferation and strong resistance to docetaxel in nasopharyngeal carcinoma. | Braz J Med Biol Res | 2025 | 39907411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=2